Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Bumetanide, sold under the brand name Bumex among others, is a medication used to treat swelling and high blood pressure. This includes swelling as a result of heart failure, liver failure, or kidney problems. It may work for swelling when other medications have not. For high blood pressure it is not a preferred treatment. It is taken by mouth, or by…
Community, Culture, Research & Art
Explore the main themes, entities and connections around Bumetanide. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
blood effects swelling pressure may treatment kidney side muscle medication acid high problems include low pregnancy drug sodium liver mouth
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Bumetanide | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Bumetanide | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Bumetanide | ATC code | C03CA02 (WHO) | 1.00 | infobox |
| Bumetanide | Bioavailability | Almost complete (~80%) | 1.00 | infobox |
| Bumetanide | CAS Number | 28395-03-1 Y | 1.00 | infobox |
| Bumetanide | ChEBI | CHEBI:3213 Y | 1.00 | infobox |
| Bumetanide | ChEMBL | ChEMBL1072 Y | 1.00 | infobox |
| Bumetanide | ChemSpider | 2377 Y | 1.00 | infobox |
| Bumetanide | CompTox Dashboard (EPA) | DTXSID5022699 | 1.00 | infobox |
| Bumetanide | DrugBank | DB00887 Y | 1.00 | infobox |
| Bumetanide | ECHA InfoCard | 100.044.534 | 1.00 | infobox |
| Bumetanide | Elimination half-life | ~0.8 hours | 1.00 | infobox |
| Bumetanide | Excretion | Kidney | 1.00 | infobox |
| Bumetanide | Formula | C17H20N2O5S | 1.00 | infobox |
| Bumetanide | IUPHAR/BPS | 4837 | 1.00 | infobox |
| Bumetanide | KEGG | D00247 Y | 1.00 | infobox |
| Bumetanide | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Bumetanide | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Bumetanide | Legal status | US: ℞-only | 1.00 | infobox |
| Bumetanide | License data | US DailyMed: Bumetanide | 1.00 | infobox |
| Bumetanide | MedlinePlus | a684051 | 1.00 | infobox |
| Bumetanide | Metabolism | Liver | 1.00 | infobox |
| Bumetanide | Molar mass | 364.42 g·mol−1 | 1.00 | infobox |
| Bumetanide | Pregnancy category | AU: B3 | 1.00 | infobox |
| Bumetanide | Protein binding | 97% | 1.00 | infobox |
| Bumetanide | PubChem CID | 2471 | 1.00 | infobox |
| Bumetanide | Routes of administration | By mouth, intravenous, intramuscular, intranasal | 1.00 | infobox |
| Bumetanide | Trade names | Bumex, Burinex, Enbumyst others | 1.00 | infobox |
| Bumetanide | UNII | 0Y2S3XUQ5H | 1.00 | infobox |
| Bumetanide | is a | loop diuretic and works by decreasing the reabsorption of sodium by the kidneys.Bumetanide was patented in 1968 and came into medical use in 1972 | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.